Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study

NCT05782972 is registered in ClinicalTrials.gov with Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation as lead sponsor.

NCT NCT05782972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05782972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study
Lead sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 11, 2023
Completion date
December 31, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic associated fatty liver disease